APO Research
Talk to an analyst

APO RESEARCH · REPORT

Atracurium Besylate Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Atracurium Besylate Injection Market Analysis and Forecast 2026-2032

21 December 2025198 pages

Choose your research edition.

Industry ResearchAtracurium Besylate Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Atracurium Besylate Injection Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Atracurium Besylate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atracurium Besylate Injection Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Atracurium Besylate Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Atracurium Besylate Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Atracurium Besylate Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Atracurium Besylate Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Atracurium Besylate Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Atracurium Besylate Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Atracurium Besylate Injection include Qilu Pharma, Pfizer, Hengrui Medicine, GSK, SGPharma, Samarth Life Sciences, Lexicare Pharma, HBM Pharma and Gland Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Atracurium Besylate Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Atracurium Besylate Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Atracurium Besylate Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Atracurium Besylate Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Atracurium Besylate Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Atracurium Besylate Injection sales, projected growth trends, production technology, application and end-user industry.

Atracurium Besylate Injection Segment by Company

Qilu Pharma

Pfizer

Hengrui Medicine

GSK

SGPharma

Samarth Life Sciences

Lexicare Pharma

HBM Pharma

Gland Pharma

Flagship Biotech

Centurion Healthcare

American Remedies Healthcare

Atracurium Besylate Injection Segment by Type

2.5ml:12.5mg

5ml:25mg

Atracurium Besylate Injection Segment by Application

Surgery

Medical Examination

Atracurium Besylate Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atracurium Besylate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atracurium Besylate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atracurium Besylate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Atracurium Besylate Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Atracurium Besylate Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Atracurium Besylate Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Atracurium Besylate Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 2.5ml:12.5mg Major Manufacturers Table 3. 5ml:25mg Major Manufacturers Table 4. Global Atracurium Besylate Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Surgery Major Manufacturers Table 6. Medical Examination Major Manufacturers Table 7. Atracurium Besylate Injection Industry Trends Table 8. Atracurium Besylate Injection Industry Drivers Table 9. Atracurium Besylate Injection Industry Opportunities and Challenges Table 10. Atracurium Besylate Injection Industry Restraints Table 11. Global Atracurium Besylate Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Atracurium Besylate Injection Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Atracurium Besylate Injection Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Atracurium Besylate Injection Revenue Market Share by Region (2021-2026) Table 15. Global Atracurium Besylate Injection Revenue Market Share by Region (2027-2032) Table 16. Global Atracurium Besylate Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (L) Table 17. Global Atracurium Besylate Injection Sales by Region (2021-2026) & (L) Table 18. Global Atracurium Besylate Injection Sales by Region (2027-2032) & (L) Table 19. Global Atracurium Besylate Injection Sales Market Share by Region (2021-2026) Table 20. Global Atracurium Besylate Injection Sales Market Share by Region (2027-2032) Table 21. Global Atracurium Besylate Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Atracurium Besylate Injection Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Atracurium Besylate Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Atracurium Besylate Injection Sales Market Share by Manufacturers (2021-2026) Table 25. Global Atracurium Besylate Injection Sales Price (US$/ml) of Manufacturers (2021-2026) Table 26. Global Atracurium Besylate Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Atracurium Besylate Injection Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Atracurium Besylate Injection Manufacturers, Product Type & Application Table 29. Global Atracurium Besylate Injection Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Atracurium Besylate Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Atracurium Besylate Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Atracurium Besylate Injection Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Atracurium Besylate Injection Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Atracurium Besylate Injection Revenue Market Share by Type (2021-2026) Table 36. Global Atracurium Besylate Injection Revenue Market Share by Type (2027-2032) Table 37. Global Atracurium Besylate Injection Sales by Type 2021 VS 2025 VS 2032 (L) Table 38. Global Atracurium Besylate Injection Sales by Type (2021-2026) & (L) Table 39. Global Atracurium Besylate Injection Sales by Type (2027-2032) & (L) Table 40. Global Atracurium Besylate Injection Sales Market Share by Type (2021-2026) Table 41. Global Atracurium Besylate Injection Sales Market Share by Type (2027-2032) Table 42. Global Atracurium Besylate Injection Price by Type (2021-2026) & (US$/ml) Table 43. Global Atracurium Besylate Injection Price by Type (2027-2032) & (US$/ml) Table 44. Global Atracurium Besylate Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Atracurium Besylate Injection Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Atracurium Besylate Injection Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Atracurium Besylate Injection Revenue Market Share by Application (2021-2026) Table 48. Global Atracurium Besylate Injection Revenue Market Share by Application (2027-2032) Table 49. Global Atracurium Besylate Injection Sales by Application 2021 VS 2025 VS 2032 (L) Table 50. Global Atracurium Besylate Injection Sales by Application (2021-2026) & (L) Table 51. Global Atracurium Besylate Injection Sales by Application (2027-2032) & (L) Table 52. Global Atracurium Besylate Injection Sales Market Share by Application (2021-2026) Table 53. Global Atracurium Besylate Injection Sales Market Share by Application (2027-2032) Table 54. Global Atracurium Besylate Injection Price by Application (2021-2026) & (US$/ml) Table 55. Global Atracurium Besylate Injection Price by Application (2027-2032) & (US$/ml) Table 56. Qilu Pharma Company Information Table 57. Qilu Pharma Business Overview Table 58. Qilu Pharma Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 59. Qilu Pharma Atracurium Besylate Injection Product Portfolio Table 60. Qilu Pharma Recent Development Table 61. Pfizer Company Information Table 62. Pfizer Business Overview Table 63. Pfizer Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 64. Pfizer Atracurium Besylate Injection Product Portfolio Table 65. Pfizer Recent Development Table 66. Hengrui Medicine Company Information Table 67. Hengrui Medicine Business Overview Table 68. Hengrui Medicine Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 69. Hengrui Medicine Atracurium Besylate Injection Product Portfolio Table 70. Hengrui Medicine Recent Development Table 71. GSK Company Information Table 72. GSK Business Overview Table 73. GSK Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 74. GSK Atracurium Besylate Injection Product Portfolio Table 75. GSK Recent Development Table 76. SGPharma Company Information Table 77. SGPharma Business Overview Table 78. SGPharma Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 79. SGPharma Atracurium Besylate Injection Product Portfolio Table 80. SGPharma Recent Development Table 81. Samarth Life Sciences Company Information Table 82. Samarth Life Sciences Business Overview Table 83. Samarth Life Sciences Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 84. Samarth Life Sciences Atracurium Besylate Injection Product Portfolio Table 85. Samarth Life Sciences Recent Development Table 86. Lexicare Pharma Company Information Table 87. Lexicare Pharma Business Overview Table 88. Lexicare Pharma Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 89. Lexicare Pharma Atracurium Besylate Injection Product Portfolio Table 90. Lexicare Pharma Recent Development Table 91. HBM Pharma Company Information Table 92. HBM Pharma Business Overview Table 93. HBM Pharma Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 94. HBM Pharma Atracurium Besylate Injection Product Portfolio Table 95. HBM Pharma Recent Development Table 96. Gland Pharma Company Information Table 97. Gland Pharma Business Overview Table 98. Gland Pharma Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 99. Gland Pharma Atracurium Besylate Injection Product Portfolio Table 100. Gland Pharma Recent Development Table 101. Flagship Biotech Company Information Table 102. Flagship Biotech Business Overview Table 103. Flagship Biotech Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 104. Flagship Biotech Atracurium Besylate Injection Product Portfolio Table 105. Flagship Biotech Recent Development Table 106. Centurion Healthcare Company Information Table 107. Centurion Healthcare Business Overview Table 108. Centurion Healthcare Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 109. Centurion Healthcare Atracurium Besylate Injection Product Portfolio Table 110. Centurion Healthcare Recent Development Table 111. American Remedies Healthcare Company Information Table 112. American Remedies Healthcare Business Overview Table 113. American Remedies Healthcare Atracurium Besylate Injection Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 114. American Remedies Healthcare Atracurium Besylate Injection Product Portfolio Table 115. American Remedies Healthcare Recent Development Table 116. North America Atracurium Besylate Injection Revenue by Type (2021-2026) & (US$ Million) Table 117. North America Atracurium Besylate Injection Revenue by Type (2027-2032) & (US$ Million) Table 118. North America Atracurium Besylate Injection Sales by Type (2021-2026) & (L) Table 119. North America Atracurium Besylate Injection Sales by Type (2027-2032) & (L) Table 120. North America Atracurium Besylate Injection Sales Price by Type (2021-2026) & (US$/ml) Table 121. North America Atracurium Besylate Injection Sales Price by Type (2027-2032) & (US$/ml) Table 122. North America Atracurium Besylate Injection Revenue by Application (2021-2026) & (US$ Million) Table 123. North America Atracurium Besylate Injection Revenue by Application (2027-2032) & (US$ Million) Table 124. North America Atracurium Besylate Injection Sales by Application (2021-2026) & (L) Table 125. North America Atracurium Besylate Injection Sales by Application (2027-2032) & (L) Table 126. North America Atracurium Besylate Injection Sales Price by Application (2021-2026) & (US$/ml) Table 127. North America Atracurium Besylate Injection Sales Price by Application (2027-2032) & (US$/ml) Table 128. North America Atracurium Besylate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Atracurium Besylate Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. North America Atracurium Besylate Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. North America Atracurium Besylate Injection Sales by Country (2021 VS 2025 VS 2032) & (L) Table 132. North America Atracurium Besylate Injection Sales by Country (2021-2026) & (L) Table 133. North America Atracurium Besylate Injection Sales by Country (2027-2032) & (L) Table 134. North America Atracurium Besylate Injection Sales Price by Country (2021-2026) & (US$/ml) Table 135. North America Atracurium Besylate Injection Sales Price by Country (2027-2032) & (US$/ml) Table 136. United States Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 137. Canada Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 138. Mexico Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 139. Europe Atracurium Besylate Injection Revenue by Type (2021-2026) & (US$ Million) Table 140. Europe Atracurium Besylate Injection Revenue by Type (2027-2032) & (US$ Million) Table 141. Europe Atracurium Besylate Injection Sales by Type (2021-2026) & (L) Table 142. Europe Atracurium Besylate Injection Sales by Type (2027-2032) & (L) Table 143. Europe Atracurium Besylate Injection Sales Price by Type (2021-2026) & (US$/ml) Table 144. Europe Atracurium Besylate Injection Sales Price by Type (2027-2032) & (US$/ml) Table 145. Europe Atracurium Besylate Injection Revenue by Application (2021-2026) & (US$ Million) Table 146. Europe Atracurium Besylate Injection Revenue by Application (2027-2032) & (US$ Million) Table 147. Europe Atracurium Besylate Injection Sales by Application (2021-2026) & (L) Table 148. Europe Atracurium Besylate Injection Sales by Application (2027-2032) & (L) Table 149. Europe Atracurium Besylate Injection Sales Price by Application (2021-2026) & (US$/ml) Table 150. Europe Atracurium Besylate Injection Sales Price by Application (2027-2032) & (US$/ml) Table 151. Europe Atracurium Besylate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Europe Atracurium Besylate Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 153. Europe Atracurium Besylate Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 154. Europe Atracurium Besylate Injection Sales by Country (2021 VS 2025 VS 2032) & (L) Table 155. Europe Atracurium Besylate Injection Sales by Country (2021-2026) & (L) Table 156. Europe Atracurium Besylate Injection Sales by Country (2027-2032) & (L) Table 157. Europe Atracurium Besylate Injection Sales Price by Country (2021-2026) & (US$/ml) Table 158. Europe Atracurium Besylate Injection Sales Price by Country (2027-2032) & (US$/ml) Table 159. Germany Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 160. France Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 161. U.K. Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 162. Italy Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 163. Russia Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 164. Spain Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 165. Netherlands Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 166. Switzerland Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 167. Sweden Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 168. Poland Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 169. China Atracurium Besylate Injection Revenue by Type (2021-2026) & (US$ Million) Table 170. China Atracurium Besylate Injection Revenue by Type (2027-2032) & (US$ Million) Table 171. China Atracurium Besylate Injection Sales by Type (2021-2026) & (L) Table 172. China Atracurium Besylate Injection Sales by Type (2027-2032) & (L) Table 173. China Atracurium Besylate Injection Sales Price by Type (2021-2026) & (US$/ml) Table 174. China Atracurium Besylate Injection Sales Price by Type (2027-2032) & (US$/ml) Table 175. China Atracurium Besylate Injection Revenue by Application (2021-2026) & (US$ Million) Table 176. China Atracurium Besylate Injection Revenue by Application (2027-2032) & (US$ Million) Table 177. China Atracurium Besylate Injection Sales by Application (2021-2026) & (L) Table 178. China Atracurium Besylate Injection Sales by Application (2027-2032) & (L) Table 179. China Atracurium Besylate Injection Sales Price by Application (2021-2026) & (US$/ml) Table 180. China Atracurium Besylate Injection Sales Price by Application (2027-2032) & (US$/ml) Table 181. Asia Atracurium Besylate Injection Revenue by Type (2021-2026) & (US$ Million) Table 182. Asia Atracurium Besylate Injection Revenue by Type (2027-2032) & (US$ Million) Table 183. Asia Atracurium Besylate Injection Sales by Type (2021-2026) & (L) Table 184. Asia Atracurium Besylate Injection Sales by Type (2027-2032) & (L) Table 185. Asia Atracurium Besylate Injection Sales Price by Type (2021-2026) & (US$/ml) Table 186. Asia Atracurium Besylate Injection Sales Price by Type (2027-2032) & (US$/ml) Table 187. Asia Atracurium Besylate Injection Revenue by Application (2021-2026) & (US$ Million) Table 188. Asia Atracurium Besylate Injection Revenue by Application (2027-2032) & (US$ Million) Table 189. Asia Atracurium Besylate Injection Sales by Application (2021-2026) & (L) Table 190. Asia Atracurium Besylate Injection Sales by Application (2027-2032) & (L) Table 191. Asia Atracurium Besylate Injection Sales Price by Application (2021-2026) & (US$/ml) Table 192. Asia Atracurium Besylate Injection Sales Price by Application (2027-2032) & (US$/ml) Table 193. Asia Atracurium Besylate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. Asia Atracurium Besylate Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. Asia Atracurium Besylate Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. Asia Atracurium Besylate Injection Sales by Country (2021 VS 2025 VS 2032) & (L) Table 197. Asia Atracurium Besylate Injection Sales by Country (2021-2026) & (L) Table 198. Asia Atracurium Besylate Injection Sales by Country (2027-2032) & (L) Table 199. Asia Atracurium Besylate Injection Sales Price by Country (2021-2026) & (US$/ml) Table 200. Asia Atracurium Besylate Injection Sales Price by Country (2027-2032) & (US$/ml) Table 201. Japan Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 202. South Korea Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 203. India Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 204. Australia Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 205. Taiwan Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 206. Southeast Asia Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 207. SAMEA Atracurium Besylate Injection Revenue by Type (2021-2026) & (US$ Million) Table 208. SAMEA Atracurium Besylate Injection Revenue by Type (2027-2032) & (US$ Million) Table 209. SAMEA Atracurium Besylate Injection Sales by Type (2021-2026) & (L) Table 210. SAMEA Atracurium Besylate Injection Sales by Type (2027-2032) & (L) Table 211. SAMEA Atracurium Besylate Injection Sales Price by Type (2021-2026) & (US$/ml) Table 212. SAMEA Atracurium Besylate Injection Sales Price by Type (2027-2032) & (US$/ml) Table 213. SAMEA Atracurium Besylate Injection Revenue by Application (2021-2026) & (US$ Million) Table 214. SAMEA Atracurium Besylate Injection Revenue by Application (2027-2032) & (US$ Million) Table 215. SAMEA Atracurium Besylate Injection Sales by Application (2021-2026) & (L) Table 216. SAMEA Atracurium Besylate Injection Sales by Application (2027-2032) & (L) Table 217. SAMEA Atracurium Besylate Injection Sales Price by Application (2021-2026) & (US$/ml) Table 218. SAMEA Atracurium Besylate Injection Sales Price by Application (2027-2032) & (US$/ml) Table 219. SAMEA Atracurium Besylate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 220. SAMEA Atracurium Besylate Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 221. SAMEA Atracurium Besylate Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 222. SAMEA Atracurium Besylate Injection Sales by Country (2021 VS 2025 VS 2032) & (L) Table 223. SAMEA Atracurium Besylate Injection Sales by Country (2021-2026) & (L) Table 224. SAMEA Atracurium Besylate Injection Sales by Country (2027-2032) & (L) Table 225. SAMEA Atracurium Besylate Injection Sales Price by Country (2021-2026) & (US$/ml) Table 226. SAMEA Atracurium Besylate Injection Sales Price by Country (2027-2032) & (US$/ml) Table 227. Brazil Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 228. Argentina Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 229. Chile Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 230. Colombia Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 231. Peru Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 232. Saudi Arabia Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 233. Israel Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 234. UAE Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 235. Turkey Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 236. Iran Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 237. Egypt Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Table 238. Key Raw Materials Table 239. Raw Materials Key Suppliers Table 240. Atracurium Besylate Injection Distributors List Table 241. Atracurium Besylate Injection Customers List Table 242. Research Programs/Design for This Report Table 243. Authors List of This Report Table 244. Secondary Sources Table 245. Primary Sources List of Figures Figure 1. Atracurium Besylate Injection Image Figure 2. Global Atracurium Besylate Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atracurium Besylate Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 2.5ml:12.5mg Image Figure 5. 5ml:25mg Image Figure 6. Global Atracurium Besylate Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Atracurium Besylate Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Surgery Image Figure 9. Medical Examination Image Figure 10. Global Atracurium Besylate Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Atracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Figure 12. Global Atracurium Besylate Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Atracurium Besylate Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Atracurium Besylate Injection Revenue Market Share by Region (2021-2032) Figure 15. Global Atracurium Besylate Injection Sales (2021-2032) & (L) Figure 16. Global Atracurium Besylate Injection Sales by Region: 2021 VS 2025 VS 2032 (L) Figure 17. Global Atracurium Besylate Injection Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Atracurium Besylate Injection Sales YoY (2021-2032) & (L) Figure 19. Europe Atracurium Besylate Injection Sales YoY (2021-2032) & (L) Figure 20. China Atracurium Besylate Injection Sales YoY (2021-2032) & (L) Figure 21. Asia (Excluding China) Atracurium Besylate Injection Sales YoY (2021-2032) & (L) Figure 22. South America, Middle East and Africa Atracurium Besylate Injection Sales YoY (2021-2032) & (L) Figure 23. Global Atracurium Besylate Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Atracurium Besylate Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Atracurium Besylate Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Atracurium Besylate Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Atracurium Besylate Injection Revenue Market Share by Type (2021-2032) Figure 29. Global Atracurium Besylate Injection Sales by Type (2021 VS 2025 VS 2032) & (L) Figure 30. Global Atracurium Besylate Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Atracurium Besylate Injection Sales Market Share by Type (2021-2032) Figure 32. Global Atracurium Besylate Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Atracurium Besylate Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Atracurium Besylate Injection Revenue Market Share by Application (2021-2032) Figure 35. Global Atracurium Besylate Injection Sales by Application (2021 VS 2025 VS 2032) & (L) Figure 36. Global Atracurium Besylate Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Atracurium Besylate Injection Sales Market Share by Application (2021-2032) Figure 38. North America Atracurium Besylate Injection Revenue Share by Type (2021-2032) Figure 39. North America Atracurium Besylate Injection Sales Share by Type (2021-2032) Figure 40. North America Atracurium Besylate Injection Revenue Share by Application (2021-2032) Figure 41. North America Atracurium Besylate Injection Sales Share by Application (2021-2032) Figure 42. North America Atracurium Besylate Injection Revenue Share by Country (2021-2032) Figure 43. North America Atracurium Besylate Injection Sales Share by Country (2021-2032) Figure 44. Europe Atracurium Besylate Injection Revenue Share by Type (2021-2032) Figure 45. Europe Atracurium Besylate Injection Sales Share by Type (2021-2032) Figure 46. Europe Atracurium Besylate Injection Revenue Share by Application (2021-2032) Figure 47. Europe Atracurium Besylate Injection Sales Share by Application (2021-2032) Figure 48. Europe Atracurium Besylate Injection Revenue Share by Country (2021-2032) Figure 49. Europe Atracurium Besylate Injection Sales Share by Country (2021-2032) Figure 50. China Atracurium Besylate Injection Revenue Share by Type (2021-2032) Figure 51. China Atracurium Besylate Injection Sales Share by Type (2021-2032) Figure 52. China Atracurium Besylate Injection Revenue Share by Application (2021-2032) Figure 53. China Atracurium Besylate Injection Sales Share by Application (2021-2032) Figure 54. Asia Atracurium Besylate Injection Revenue Share by Type (2021-2032) Figure 55. Asia Atracurium Besylate Injection Sales Share by Type (2021-2032) Figure 56. Asia Atracurium Besylate Injection Revenue Share by Application (2021-2032) Figure 57. Asia Atracurium Besylate Injection Sales Share by Application (2021-2032) Figure 58. Asia Atracurium Besylate Injection Revenue Share by Country (2021-2032) Figure 59. Asia Atracurium Besylate Injection Sales Share by Country (2021-2032) Figure 60. SAMEA Atracurium Besylate Injection Revenue Share by Type (2021-2032) Figure 61. SAMEA Atracurium Besylate Injection Sales Share by Type (2021-2032) Figure 62. SAMEA Atracurium Besylate Injection Revenue Share by Application (2021-2032) Figure 63. SAMEA Atracurium Besylate Injection Sales Share by Application (2021-2032) Figure 64. SAMEA Atracurium Besylate Injection Revenue Share by Country (2021-2032) Figure 65. SAMEA Atracurium Besylate Injection Sales Share by Country (2021-2032) Figure 66. Atracurium Besylate Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Atracurium Besylate Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5ml:12.5mg
  • 5ml:25mg
Applications
  • Surgery
  • Medical Examination
Companies covered
  • Qilu Pharma
  • Pfizer
  • Hengrui Medicine
  • GSK
  • SGPharma
  • Samarth Life Sciences
  • Lexicare Pharma
  • HBM Pharma
  • Gland Pharma
  • Flagship Biotech
  • Centurion Healthcare
  • American Remedies Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Atracurium Besylate Injection Market by Type
  3. 1.2.1 Global Atracurium Besylate Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 2.5ml:12.5mg
  5. 1.2.3 5ml:25mg
  6. 1.3 Atracurium Besylate Injection Market by Application
  7. 1.3.1 Global Atracurium Besylate Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Surgery
  9. 1.3.3 Medical Examination
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Atracurium Besylate Injection Market Dynamics
  1. 2.1 Atracurium Besylate Injection Industry Trends
  2. 2.2 Atracurium Besylate Injection Industry Drivers
  3. 2.3 Atracurium Besylate Injection Industry Opportunities and Challenges
  4. 2.4 Atracurium Besylate Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Atracurium Besylate Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Atracurium Besylate Injection Revenue by Region
  3. 3.2.1 Global Atracurium Besylate Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Atracurium Besylate Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Atracurium Besylate Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Atracurium Besylate Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Atracurium Besylate Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Atracurium Besylate Injection Sales by Region
  9. 3.4.1 Global Atracurium Besylate Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Atracurium Besylate Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Atracurium Besylate Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Atracurium Besylate Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Atracurium Besylate Injection Revenue by Manufacturers
  2. 4.1.1 Global Atracurium Besylate Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Atracurium Besylate Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Atracurium Besylate Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Atracurium Besylate Injection Sales by Manufacturers
  6. 4.2.1 Global Atracurium Besylate Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Atracurium Besylate Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Atracurium Besylate Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Atracurium Besylate Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Atracurium Besylate Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Atracurium Besylate Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Atracurium Besylate Injection Manufacturers, Product Type & Application
  13. 4.7 Global Atracurium Besylate Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Atracurium Besylate Injection Market CR5 and HHI
  16. 4.8.2 2025 Atracurium Besylate Injection Tier 1, Tier 2, and Tier 3
5 Atracurium Besylate Injection Market by Type
  1. 5.1 Global Atracurium Besylate Injection Revenue by Type
  2. 5.1.1 Global Atracurium Besylate Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Atracurium Besylate Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Atracurium Besylate Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Atracurium Besylate Injection Sales by Type
  6. 5.2.1 Global Atracurium Besylate Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Atracurium Besylate Injection Sales by Type (2021-2032) & (L)
  8. 5.2.3 Global Atracurium Besylate Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Atracurium Besylate Injection Price by Type
6 Atracurium Besylate Injection Market by Application
  1. 6.1 Global Atracurium Besylate Injection Revenue by Application
  2. 6.1.1 Global Atracurium Besylate Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Atracurium Besylate Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Atracurium Besylate Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Atracurium Besylate Injection Sales by Application
  6. 6.2.1 Global Atracurium Besylate Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Atracurium Besylate Injection Sales by Application (2021-2032) & (L)
  8. 6.2.3 Global Atracurium Besylate Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Atracurium Besylate Injection Price by Application
7 Company Profiles
  1. 7.1 Qilu Pharma
  2. 7.1.1 Qilu Pharma Company Information
  3. 7.1.2 Qilu Pharma Business Overview
  4. 7.1.3 Qilu Pharma Atracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Qilu Pharma Atracurium Besylate Injection Product Portfolio
  6. 7.1.5 Qilu Pharma Recent Developments
  7. 7.2 Pfizer
  8. 7.2.1 Pfizer Company Information
  9. 7.2.2 Pfizer Business Overview
  10. 7.2.3 Pfizer Atracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Atracurium Besylate Injection Product Portfolio
  12. 7.2.5 Pfizer Recent Developments
  13. 7.3 Hengrui Medicine
  14. 7.3.1 Hengrui Medicine Company Information
  15. 7.3.2 Hengrui Medicine Business Overview
  16. 7.3.3 Hengrui Medicine Atracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Hengrui Medicine Atracurium Besylate Injection Product Portfolio
  18. 7.3.5 Hengrui Medicine Recent Developments
  19. 7.4 GSK
  20. 7.4.1 GSK Company Information
  21. 7.4.2 GSK Business Overview
  22. 7.4.3 GSK Atracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GSK Atracurium Besylate Injection Product Portfolio
  24. 7.4.5 GSK Recent Developments
  25. 7.5 SGPharma
  26. 7.5.1 SGPharma Company Information
  27. 7.5.2 SGPharma Business Overview
  28. 7.5.3 SGPharma Atracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 SGPharma Atracurium Besylate Injection Product Portfolio
  30. 7.5.5 SGPharma Recent Developments
  31. 7.6 Samarth Life Sciences
  32. 7.6.1 Samarth Life Sciences Company Information
  33. 7.6.2 Samarth Life Sciences Business Overview
  34. 7.6.3 Samarth Life Sciences Atracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Samarth Life Sciences Atracurium Besylate Injection Product Portfolio
  36. 7.6.5 Samarth Life Sciences Recent Developments
  37. 7.7 Lexicare Pharma
  38. 7.7.1 Lexicare Pharma Company Information
  39. 7.7.2 Lexicare Pharma Business Overview
  40. 7.7.3 Lexicare Pharma Atracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Lexicare Pharma Atracurium Besylate Injection Product Portfolio
  42. 7.7.5 Lexicare Pharma Recent Developments
  43. 7.8 HBM Pharma
  44. 7.8.1 HBM Pharma Company Information
  45. 7.8.2 HBM Pharma Business Overview
  46. 7.8.3 HBM Pharma Atracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 HBM Pharma Atracurium Besylate Injection Product Portfolio
  48. 7.8.5 HBM Pharma Recent Developments
  49. 7.9 Gland Pharma
  50. 7.9.1 Gland Pharma Company Information
  51. 7.9.2 Gland Pharma Business Overview
  52. 7.9.3 Gland Pharma Atracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Gland Pharma Atracurium Besylate Injection Product Portfolio
  54. 7.9.5 Gland Pharma Recent Developments
  55. 7.10 Flagship Biotech
  56. 7.10.1 Flagship Biotech Company Information
  57. 7.10.2 Flagship Biotech Business Overview
  58. 7.10.3 Flagship Biotech Atracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Flagship Biotech Atracurium Besylate Injection Product Portfolio
  60. 7.10.5 Flagship Biotech Recent Developments
  61. 7.11 Centurion Healthcare
  62. 7.11.1 Centurion Healthcare Company Information
  63. 7.11.2 Centurion Healthcare Business Overview
  64. 7.11.3 Centurion Healthcare Atracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Centurion Healthcare Atracurium Besylate Injection Product Portfolio
  66. 7.11.5 Centurion Healthcare Recent Developments
  67. 7.12 American Remedies Healthcare
  68. 7.12.1 American Remedies Healthcare Company Information
  69. 7.12.2 American Remedies Healthcare Business Overview
  70. 7.12.3 American Remedies Healthcare Atracurium Besylate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 American Remedies Healthcare Atracurium Besylate Injection Product Portfolio
  72. 7.12.5 American Remedies Healthcare Recent Developments
8 North America
  1. 8.1 North America Atracurium Besylate Injection Market Size by Type
  2. 8.1.1 North America Atracurium Besylate Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Atracurium Besylate Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Atracurium Besylate Injection Price by Type (2021-2032)
  5. 8.2 North America Atracurium Besylate Injection Market Size by Application
  6. 8.2.1 North America Atracurium Besylate Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Atracurium Besylate Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Atracurium Besylate Injection Price by Application (2021-2032)
  9. 8.3 North America Atracurium Besylate Injection Market Size by Country
  10. 8.3.1 North America Atracurium Besylate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Atracurium Besylate Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Atracurium Besylate Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Atracurium Besylate Injection Market Size by Type
  2. 9.1.1 Europe Atracurium Besylate Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Atracurium Besylate Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Atracurium Besylate Injection Price by Type (2021-2032)
  5. 9.2 Europe Atracurium Besylate Injection Market Size by Application
  6. 9.2.1 Europe Atracurium Besylate Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Atracurium Besylate Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Atracurium Besylate Injection Price by Application (2021-2032)
  9. 9.3 Europe Atracurium Besylate Injection Market Size by Country
  10. 9.3.1 Europe Atracurium Besylate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Atracurium Besylate Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Atracurium Besylate Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Atracurium Besylate Injection Market Size by Type
  2. 10.1.1 China Atracurium Besylate Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Atracurium Besylate Injection Sales by Type (2021-2032)
  4. 10.1.3 China Atracurium Besylate Injection Price by Type (2021-2032)
  5. 10.2 China Atracurium Besylate Injection Market Size by Application
  6. 10.2.1 China Atracurium Besylate Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Atracurium Besylate Injection Sales by Application (2021-2032)
  8. 10.2.3 China Atracurium Besylate Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Atracurium Besylate Injection Market Size by Type
  2. 11.1.1 Asia Atracurium Besylate Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Atracurium Besylate Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Atracurium Besylate Injection Price by Type (2021-2032)
  5. 11.2 Asia Atracurium Besylate Injection Market Size by Application
  6. 11.2.1 Asia Atracurium Besylate Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Atracurium Besylate Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Atracurium Besylate Injection Price by Application (2021-2032)
  9. 11.3 Asia Atracurium Besylate Injection Market Size by Country
  10. 11.3.1 Asia Atracurium Besylate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Atracurium Besylate Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Atracurium Besylate Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Atracurium Besylate Injection Market Size by Type
  2. 12.1.1 SAMEA Atracurium Besylate Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Atracurium Besylate Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Atracurium Besylate Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Atracurium Besylate Injection Market Size by Application
  6. 12.2.1 SAMEA Atracurium Besylate Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Atracurium Besylate Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Atracurium Besylate Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Atracurium Besylate Injection Market Size by Country
  10. 12.3.1 SAMEA Atracurium Besylate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Atracurium Besylate Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Atracurium Besylate Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Atracurium Besylate Injection Value Chain Analysis
  2. 13.1.1 Atracurium Besylate Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Atracurium Besylate Injection Production Mode & Process
  6. 13.2 Atracurium Besylate Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Atracurium Besylate Injection Distributors
  9. 13.2.3 Atracurium Besylate Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst